Luisa Müller/ unimedizin-greifswald.de
Jul 13, 2026, 11:25
Luisa Müller: Advancing Anticoagulation Strategies for VITT at ISTH 2026
Luisa Müller, Research Associate at University Medicine Greifswald, shared a post on LinkedIn:
“First day at ISTH 2026 in Paris with our VITT working group from Greifswald. Looking forward to many insightful presentations, meaningful discussions and meeting old and new friends.
I would be very happy to meet some of you at my poster presentation:
Presentation Title: Therapeutic anticoagulation in a murine model of vaccine-induced immune thrombocytopenia and thrombosis (VITT)
Abstract Presentation/Board Number: PB1527
Date and Time of Poster Presentation: 07/12/2026 at 13:45 – 14:45
Poster Location: Exhibition Hall”
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 16:44The Evolving Treatment Landscape of Hemophilia: From Factor Replacement to Gene Therapy
-
Aug 11, 2026, 16:34Advancing Hemophilia Care Through Training and Local Capacity Building – WFH
-
Aug 11, 2026, 16:26Sabrina H.: The Spectrum of PF4-Mediated Thrombotic Disorders
-
Aug 11, 2026, 16:17Mandy Lauw: From CRTH Training to Clinical Trials
-
Aug 11, 2026, 16:05Obi Light Ogbonnia: From 52 Years of Living With Sickle Cell to a Global Stage
-
Aug 11, 2026, 15:42Iva Pruner: Hemostasis, Thrombosis, and a Little Death Metal
-
Aug 11, 2026, 15:25Bradley Maron։ The AI Revolution in Cardiovascular Drug Development
-
Aug 11, 2026, 15:10Jared Rice: When a Negative DAT Doesn’t Mean the Alloimmune Risk Is Gone
-
Aug 11, 2026, 14:58Manuel De Jesus: Validating the Future of Point-of-Care Anemia Monitoring